Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available data
Postmastectomy radiotherapy (PMRT) has been shown to decrease locoregional recurrence and improve overall survival in patients with tumors greater than 5 cm or positive nodes. Because neoadjuvant chemotherapy (NAC) can cause significant downstaging, the indications for PMRT in the setting of NAC rem...
Main Authors: | Amar U. Kishan, Susan A. McCloskey |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834015617459 |
Similar Items
-
Postmastectomy Radiation Therapy: Are We Ready to Individualize Radiation?
by: Ashlyn S. Everett, et al.
Published: (2018-01-01) -
Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era
by: Naomi Nakajima, MD, PhD, et al.
Published: (2018-07-01) -
Breast Reconstruction Complications After Postmastectomy Proton Radiation Therapy for Breast Cancer
by: Eva Berlin, MD, et al.
Published: (2024-03-01) -
An ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy
by: Baggarley Shaun, et al.
Published: (2011-02-01) -
Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in cT1-2N+ Breast Cancer Patients: A Single Center Experience and Review of Current Literature
by: Meng Luo, et al.
Published: (2022-05-01)